NOVEL APPROACHES TO ADDRESS RESISTANCE TO ANTI PD-1/PD-L1 THERAPY IN NSCLC

被引：0
|
作者：
Sehgal, M. [1 ]
Das, N. [1 ]
Thekkadath, R. [1 ]
Mittal, N. [1 ]
Chauhan, U. [1 ]
Eswaran, S. [1 ]
机构：
[1] COURSE5 Intelligence Pvt Ltd, Bengaluru, KA, India
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN46
引用
收藏
页码：S444 / S444
页数：1
相关论文
共 50 条
  • [1] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [2] Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
    Niu, Mengke
    Yi, Ming
    Li, Ning
    Luo, Suxia
    Wu, Kongming
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)
  • [3] Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
    Mengke Niu
    Ming Yi
    Ning Li
    Suxia Luo
    Kongming Wu
    Experimental Hematology & Oncology, 10
  • [4] Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: a potential target for anti PD-1/PD-L1 therapy
    Roberts, Jordan A.
    Gonzalez, Raul S.
    Das, Satya
    Berlin, Jordan
    Shi, Chanjuan
    HUMAN PATHOLOGY, 2017, 70 : 49 - 54
  • [5] Mechanisms of Resistance to PD-1 and PD-L1 Blockade
    Nowicki, Theodore S.
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    CANCER JOURNAL, 2018, 24 (01): : 47 - 53
  • [6] Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
    Long, Yiru
    Yu, Xiaolu
    Chen, Runqiu
    Tong, Yongliang
    Gong, Likun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Whole body PD-1 and PD-L1 PET in pts with NSCLC
    Niemeijer, A-L.
    Smit, E.
    Bahce, I.
    Hoekstra, O.
    Huisman, M.
    van Dongen, G. A.
    Windhorst, B.
    Hendrikse, N.
    Poot, A. J.
    Vugts, D.
    Leung, D. K.
    Hayes, W.
    Smith, R. A.
    Wilson, L. M.
    Thunnissen, E.
    de langen, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] Whole Body PD-1 and PD-L1 PET in Pts with NSCLC
    Niemeijer, A.
    Smit, E.
    Van Dongen, G.
    Windhorst, A. D.
    Huisman, M.
    Hendrikse, N.
    Bahce, I.
    Lueng, D.
    Smith, R.
    Hayes, W.
    Wilson, L.
    Bonacorsi, S.
    Donnelly, D.
    Morin, P.
    Poot, A.
    Vugts, D.
    Thunnissen, E.
    De Langen, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1817 - S1817
  • [9] Chemotherapy + PD-1/PD-L1 Blockade Should Be the Preferred Option in the Neoadjuvant Therapy of NSCLC
    Rosner, Samuel
    Forde, Patrick M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (04) : 503 - 509
  • [10] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
12345